New nasal spray approved by FDA

A new nasal spray manufactured by ALTANA Pharma US, Inc. of Florham Park, New Jersey has been approved by the U.S. Food and Drug Administration (FDA) seasonal and perennial hay fever.
The spray contains a type of corticosteroid that is anti-inflammatory drugs and could mimic the body's hormones to increase the level of steroids in the body. This lead to the shrinking of inflamed tissue and reduction in mucus flow.